UBE2D1 and cancer: Whilst it has not been described in glioblastoma to date, our data suggests that in GIC, UBE2D1 is in a poised state which could allow the cancer cells to respond quicker to cellular stress such as hypoxia by decreasing HIF1-apha degradation and promoting angiogenesis and hence tumour maintenance in a hypoxic environment.